Trial intelligence / Profile preview

REVAXIS versus DT Polio booster at 6 years of age

2005-001446-16Phase 3Completed

Sponsor
Sanofi
Start
Jul 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3 trial of diphtheria toxoid adsorbed + tetanus toxoid adsorbed and DT Polio in diphtheria, Tetanus and poliomyelitis (2 arms), sponsored by Sanofi. Primary endpoints: Diphtheria seroprotection response, Tetanus seroprotection response and 3 more. Started Jul 2006; status: completed.

02

Drugs

diphtheria toxoid adsorbed + tetanus toxoid adsorbedDT Polio
03

Conditions

diphtheriaTetanuspoliomyelitis

Beyond the preview

Go deeper on 2005-001446-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001446-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call